Growth Metrics

Fulgent Genetics (FLGT) Total Debt (2020 - 2026)

Fulgent Genetics' Total Debt history spans 7 years, with the latest figure at $32.1 million for Q1 2026.

  • On a quarterly basis, Total Debt rose 8.24% to $32.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $32.1 million, a 8.24% increase, with the full-year FY2025 number at $30.1 million, changed 0.0% from a year prior.
  • Total Debt hit $32.1 million in Q1 2026 for Fulgent Genetics, up from $30.1 million in the prior quarter.
  • Over the last five years, Total Debt for FLGT hit a ceiling of $32.1 million in Q1 2026 and a floor of $14.3 million in Q4 2022.
  • Historically, Total Debt has averaged $24.5 million across 5 years, with a median of $29.0 million in 2022.
  • Biggest five-year swings in Total Debt: soared 347.38% in 2022 and later tumbled 50.07% in 2023.
  • Tracing FLGT's Total Debt over 5 years: stood at $14.3 million in 2022, then surged by 79.88% to $25.7 million in 2023, then increased by 17.3% to $30.1 million in 2024, then changed by 0.0% to $30.1 million in 2025, then increased by 6.62% to $32.1 million in 2026.
  • Business Quant data shows Total Debt for FLGT at $32.1 million in Q1 2026, $30.1 million in Q4 2025, and $30.5 million in Q3 2025.